William Blair & Company’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.2M Sell
34,359
-75,147
-69% -$4.94M 0.01% 734
2026
Q1
$7.79M Buy
109,506
+5,026
+5% +$396K 0.02% 404
2025
Q4
$8.57M Sell
104,480
-5,138
-5% -$400K 0.02% 391
2025
Q3
$8.23M Sell
109,618
-35,503
-24% -$2.65M 0.02% 406
2025
Q2
$10.7M Buy
145,121
+37,611
+35% +$2.62M 0.03% 333
2025
Q1
$8.68M Sell
107,510
-1,111
-1% -$95.5K 0.03% 357
2024
Q4
$8.49M Sell
108,621
-1,752
-2% -$149K 0.02% 367
2024
Q3
$10.4M Buy
110,373
+115
+0.1% +$9.65K 0.03% 338
2024
Q2
$8.59M Buy
110,258
+294
+0.3% +$24K 0.03% 350
2024
Q1
$10M Buy
109,964
+10,928
+11% +$909K 0.03% 333
2023
Q4
$7.66M Buy
99,036
+18,814
+23% +$1.32M 0.03% 365
2023
Q3
$5.46M Sell
80,222
-5,624
-7% -$409K 0.02% 417
2023
Q2
$6.97M Buy
85,846
+1,223
+1% +$97.6K 0.03% 376
2023
Q1
$6.94M Buy
+84,623
New +$6.04M 0.03% 372

Other funds holding GEHC

William Blair & Company's GEHC Position: Q2 2026 in Review

William Blair & Company reduced its GE HealthCare (GEHC) stake by 69% in Q2 2026, selling an estimated $4.94M and leaving 34,359 shares worth $2.2M. The position accounts for 0.01% of the portfolio, ranked #734.

William Blair & Company first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $10.7M in Q2 2025. 1,228 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • William Blair & Company held 34,359 shares of GE HealthCare worth $2.2M as of Q2 2026.
  • William Blair & Company sold 75,147 GE HealthCare shares in Q2 2026, an estimated $4.94M.
  • GE HealthCare made up 0.01% of William Blair & Company's portfolio in Q2 2026, its #734 holding.
  • William Blair & Company first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • William Blair & Company's GE HealthCare position peaked at $10.7M in Q2 2025.
  • 1,228 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on William Blair & Company's 13F filing for Q2 2026, filed 11 Aug 2026.